CNSP
USDCNS Pharmaceuticals Inc. Common Stock
$6.600-0.420 (-5.983%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$7.020
High
$7.020
Low
$6.500
Volume
0.01M
Company Fundamentals
Market Cap
3.8M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.05M
Exchange
NCM
Currency
USD
52-Week Range
Low $4.93Current $6.600High $114
Related News
Analyst Upgrades
Maxim Group Upgrades CNS Pharma to Buy, Announces $20 Price Target
Maxim Group analyst Jason McCarthy upgrades CNS Pharma from Hold to Buy and announces $20 price target.
View more
AccessWire
CNS Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference
HOUSTON, TX / ACCESS Newswire / September 3, 2025 / CNS Pharmaceuticals, Inc. , a biopharmaceutical company specializing in the development of novel treatments
View more
GlobeNewswire
IBN Announces Latest Episode of The BioMedWire Podcast Featuring John Climaco, CEO of CNS Pharmaceuticals Inc.
AUSTIN, Texas, Aug. 27, 2025 (GLOBE NEWSWIRE) -- -- via IBN -- IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.